Medtronic reports revenue growth in Q2, raises FY24 outlook
Post Content
Similar Posts
Asian stocks sink after stellar November, PMIs offer mixed cues
Post Content Post Views: 77
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
Pfizer said it still plans to release phase two trial data on a once-a-day version of its weight loss drug, known as danuglipron, in mid-2024. Post Views: 89
Deal-hunters fuel $12 billion Cyber Monday shopping spree
Post Content Post Views: 76
MINISO Group beats Q1 top and bottom line estimate
Post Content Post Views: 101
Elliott takes $1 billion stake in US oil refiner Phillips 66, urges board revamp
Post Content Post Views: 83
Americans celebrate Thanksgiving on edge over war in Gaza
Post Content Post Views: 90
Asian stocks sink after stellar November, PMIs offer mixed cues
Post Content Post Views: 77
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
Pfizer said it still plans to release phase two trial data on a once-a-day version of its weight loss drug, known as danuglipron, in mid-2024. Post Views: 89
Deal-hunters fuel $12 billion Cyber Monday shopping spree
Post Content Post Views: 76
MINISO Group beats Q1 top and bottom line estimate
Post Content Post Views: 101
Elliott takes $1 billion stake in US oil refiner Phillips 66, urges board revamp
Post Content Post Views: 83
Americans celebrate Thanksgiving on edge over war in Gaza
Post Content Post Views: 90
Asian stocks sink after stellar November, PMIs offer mixed cues
Post Content Post Views: 77
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
Pfizer said it still plans to release phase two trial data on a once-a-day version of its weight loss drug, known as danuglipron, in mid-2024. Post Views: 89